Smith & Nephew is an industry leader in each of our three main Global Business Units - Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. These businesses jointly offer over 1,000 product ranges.
Our global infrastructure continues to expand each year. We currently operate in 32 countries and generate annual sales of $3.4 billion. Substantial investment in our products and intensive research and development means that we are always ahead. Figures from last year show that we stand at number one as the leading company in Arthroscopy. We are the second largest organisation in Advanced Wound Management and number three in Trauma and Clinical Therapies. We are also positioned at number four in reconstruction.
Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. This is the primary focus of our fourth business unit, Biologics.
Company Growth (employees)
Key People at Smith & Nephew
Olivier Bohuon
Graham Baker
John W. Campo
Helen Maye
Philippe Mazas
Smith & Nephew Office Locations
Smith & Nephew Data and Metrics
Smith & Nephew Financial Metrics
Revenue (FY, 2016) | 3.6 b |
Revenue growth (FY, 2015 - FY, 2016), % | 13% |
Gross profit (FY, 2016) | 2.6 b |
Gross profit margin (FY, 2016), % | 73% |
Net income (FY, 2016) | 606 m |
Market capitalization (25-Jul-2017) | 477.6 m |
Closing share price (25-Jul-2017) | 6 |
Cash (31-Dec-2016) | 77.3 m |
- Source: Company Filings
| GBP | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 2.9 b | 3.2 b | 3.2 b | 3.6 b |
Revenue growth, % | 11% | 0% | 13% | |
Cost of goods sold | 724.8 m | 797.5 m | 784.4 m | 983.2 m |
Gross profit | 2.1 b | 2.4 b | 2.4 b | 2.6 b |
Gross profit Margin, % | 75% | 75% | 75% | 73% |
Operating expense total | 1.6 b | 1.9 b | 2 b | 2 b |
Pre tax profit | 528.4 m | 490 m | 383.6 m | 820.8 m |
Net Income | 366.3 m | 343.8 m | 281.4 m | 606 m |
- Source: Company Filings
| GBP | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 90.3 m | 63.8 m | 82.4 m | 77.3 m |
Accounts Receivable | 616.1 m | 664.3 m | 644.4 m | 800.7 m |
Current Assets | 1.5 b | 1.7 b | 1.7 b | 2 b |
PP&E | 825.6 m | 749.4 m | 808.5 m | 939.9 m |
Goodwill | 1.5 b | 2.6 b | 2.4 b | 2.8 b |
Total Assets | 3.8 b | 5 b | 4.9 b | 5.7 b |
Accounts Payable | 494.8 m | 553.8 m | 554.5 m | 623.7 m |
Current Liabilities | 707 m | 797.5 m | 922.4 m | 1 b |
Total Liabilities | 1.2 b | 2.2 b | 2.2 b | 2.6 b |
Retained Earnings | 208.9 m | 179.8 m | 94.7 m | 606 m |
Total Equity | 2.7 b | 2.8 b | 2.7 b | 3.1 b |
Financial Leverage | 1.4 x | 1.8 x | 1.8 x | 1.9 x |
| GBP | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash From Operating Activities | 571.3 m | 468.7 m | 706.9 m | 656.2 m |
Cash From Financing Activities | (328.1 m) | 691.8 m | (383 m) | (408.9 m) |
Income Taxes Paid | (162.1 m) | (146.2 m) | (102.3 m) | (214.9 m) |
| Y, 2016 | |
|---|---|
Financial Leverage | 1.9 x |
Smith & Nephew Operating Metrics
- Source: Company Filings
